TrialCancer prevention research (Philadelphia, Pa.)2020

Randomized Phase IIB Trial of the Lignan Secoisolariciresinol Diglucoside in Premenopausal Women at Increased Risk for Development of Breast Cancer.

Carol J Fabian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.